NGL Fine-Chem Limited (BOM:524774)
India · Delayed Price · Currency is INR 2,240.45
-2.20 (-0.10%)
At close: Feb 12, 2026
NGL Fine-Chem Market Cap
NGL Fine-Chem has a market cap or net worth of 13.84 billion as of February 13, 2026. Its market cap has increased by 30.98% in one year.
Market Cap
13.84B
Enterprise Value
14.16B
Revenue
4.49B
Ranking
n/a
PE Ratio
39.13
Stock Price
2,240.45
Market Cap Chart
Since December 24, 2004, NGL Fine-Chem's market cap has increased from 80.40M to 13.84B, an increase of 17,115.86%. That is a compound annual growth rate of 27.56%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 12, 2026 | 13.84B | 59.01% |
| Dec 31, 2025 | 8.70B | -21.72% |
| Dec 31, 2024 | 11.12B | -19.33% |
| Dec 29, 2023 | 13.79B | 44.38% |
| Dec 30, 2022 | 9.55B | -42.81% |
| Dec 31, 2021 | 16.70B | 140.04% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sudeep Pharma | 74.81B |
| Shilpa Medicare | 66.43B |
| Gujarat Themis Biosyn | 36.95B |
| Suven Life Sciences | 36.67B |
| IOL Chemicals and Pharmaceuticals | 23.74B |
| Bajaj HealthCare | 12.02B |
| Anlon Healthcare | 6.58B |
| Shree Ganesh Remedies | 6.27B |